Renalytix plc Additional Paid in Capital, Common Stock
Renalytix plc (RENXF) had Additional Paid in Capital, Common Stock of $206.71 million as of 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2024-11-19
- 2024-09-30: Additional Paid in Capital, Common Stock $206.71M.
- 2024-06-30: Additional Paid in Capital, Common Stock $204.89M.
- 2024-03-31: Additional Paid in Capital, Common Stock $194.79M.
- 2023-12-31: Additional Paid in Capital, Common Stock $190.44M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2024-09-30 | $206.71M 10-Q · filed 2024-11-19 |
| 2024-06-30 | $204.89M 10-Q · filed 2024-11-19 |
| 2024-03-31 | $194.79M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $190.44M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $188.03M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $186.46M 10-K · filed 2024-09-30 |
| 2023-03-31 | $185.87M 6-K · filed 2023-06-09 |
| 2022-12-31 | $165.71M 6-K · filed 2023-03-30 |
| 2022-09-30 | $164.89M 6-K · filed 2022-11-30 |
| 2022-06-30 | $164.01M 10-K · filed 2023-09-28 |
| 2022-03-31 | $153.60M 6-K · filed 2022-06-30 |
| 2021-12-31 | $152.66M 6-K/A · filed 2022-04-29 |
| 2021-06-30 | $150.41M 20-F · filed 2022-10-31 |
| 2020-06-30 | $69.65M 20-F/A · filed 2022-08-01 |
| 2019-06-30 | $52.08M 20-F/A · filed 2022-08-01 |